New Mountain's private equity strategy seeks to acquire the highest quality leaders in carefully selected growth industries.
New Mountain Vantage Advisers, LLC ("Vantage") holds non-control positions in the U.S. public equity market.
New Mountain’s credit strategy applies the firm’s “defensive growth” industry approach to the debt portion of the capital structure.
Matthew S. Holt
Managing Director & Deputy Head of Private Equity

Matthew Holt, also known as Matt, Managing Director, joined New Mountain in 2001. He serves as the Deputy Head of Private Equity and focuses on growth buyouts across a range of industries including healthcare products, health technology, materials and infrastructure. He previously worked in the Mergers and Acquisitions Group at Lehman Brothers from 1999 to 2001. He serves as the Lead Director or Chairman of Avantor, Inc., CIOX Health, Signify Health, Convey Health Solutions, Inc., Cytel, Equian LLC, Revint Solutions and Zep, Inc. He also serves as a Director of Topix Pharmaceuticals, Gelest, and TRC Companies. Mr. Holt has previously served as Lead Director of Bellerophon Therapeutics, Inc., Ikaria, Inc., Nusil Technology LLC, and Director of MailSouth.

Mr. Holt holds an A.B. with honors in English and American Literature and Language from Harvard College in 1999.

Back to Team By Position